GE Healthcare Technologies Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. I'm Robbie Markus, the MedTech analyst at JPMorgan.
I'm very happy to have our next session, led by CEO of GE HealthCare, Peter Arduini. Peter will do a presentation, followed by some Q&A. Pete?
Thanks, Robbie. It's still good morning, good afternoon, for those on the webcast. It's great to be out to a sunny JPMorgan.
Just kicking off, we'll use, obviously, some forward-looking statements here. A lot of our financials will be Q3 year to date. We'll give our full-year and our Q4 results on February 4, when we announce.
From just a quick overview, if you don't know super well GE Healthcare, this is the beginning of year 4 as a separate public company; focused about creating a world where healthcare has no limits -- bold statement about problem-solving and working with customers on some of the big, longitudinal challenges that exist.
Our strategy is focused
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

